Newsroom
Showing 101 - 125 of 425 results
June 2021
- $54.550 Million Bond Financing Closes for Second Phase of Stockton University Atlantic City Campus
- Barabas, Diener and Vyakarnam Promoted to Special Counsel
April 2021
- IP Licensing Litigation Team Defends Dismissal of Patent Pool Antitrust Complaint in 5th Circuit
- Scott Matthews, John Keneally Win Dismissal of $1 Million Transfer Tax Challenge
- Madoff Case Garners DOJ Support for $3B Fund Clawback from Overseas Banks
March 2021
- Karl Frederic Reps Critical Care Immunotherapy Company in Life Science and Office Lease
- City & State Recognizes Sanjay Mody in Law Power 100
- New Jersey Edition of Super Lawyers Recognizes 2 Lawyers for 2021
- Michele Arbeeny and John Bitar Close $44 Million Bond Deal on Behalf of Hellenic Classical Charter Schools
February 2021
- Tony Coscia Recognized by NJBIZ Power 100
- Tony Coscia Recognized by ROI-NJ Influencers: Power
November 2020
- Tony Coscia Named to NJBIZ Commercial Real Estate Power 50, 2020 Edition
- Windels Marx Named to the 2021 Roster of U.S. News – Best Lawyers "Best Law Firms"
October 2020
- For 2020, Super Lawyers Recognizes 17 Lawyers in New York Metro and Rising Stars Editions
September 2020
- 12,800 sf Office Lease Closes in Woodbridge, NJ
- Rob Malatak Featured in Crain's NY Business "Ask the Expert" on Workouts, Restructuring, Bankruptcy and Litigation
- IP-Hatch-Waxman Act Team Achieves Another Important Victory for Dr. Reddy's Laboratories in Icosapent Ethyl (Vascepa®)
- Public Finance Team Closes $1 Billion Bond Deal in Healthcare Industry
August 2020
- Best Lawyers in America 2021 Recognizes 22 Windels Marx Lawyers, 9 Ones to Watch, 4 Lawyers of the Year
- Windels Marx Closes First Loan Under Main Street Lending Program
- Charles Hamilton and Team Close National Urban League HQ - Most Significant Harlem Project in Decades
June 2020
- Center for Comprehensive Health Practice (CCHP) Names Ben Kusmin Interim Chair of the Board
- IP-Hatch-Waxman Act Team Garners Important Victory for Slayback Pharma Against Eagle Pharmaceuticals